Close
Help




JOURNAL

Journal of Central Nervous System Disease

166,788 Journal Article Views | Journal Analytics

Alzheimers Disease: Review of Emerging Treatment Role for Intravenous Immunoglobulins

Submit a Paper



Publication Date: 08 May 2011

Type: Review

Journal: Journal of Central Nervous System Disease

Citation: Journal of Central Nervous System Disease 2011:3 67-73

doi: 10.4137/JCNSD.S5018

Abstract

Alzheimer’s disease (AD) is the most common neurodegenerative disorder. Currently available therapies are symptomatic but do not alter underlying disease progression. Immunotherapeutic approaches such as anti Aß peptide active vaccination trials have had limited success to date. Intravenous immunoblobulin (IVIg) is widely used in immune-mediated neurological disorders such myasthenia gravis and Guillain-Barre syndrome. These preparations have been obtained from the pooled plasma of healthy human donors and contain natural anti-amyloid antibodies and are well tolerated. A small pilot study of passive immunotherapy using IVIg has suggested cognitive improvement. A multicenter phase III trial is ongoing and will determine whether or not this treatment can ameliorate cognitive deficits in mild-to-moderate AD. Here, we briefly review the pathogenic role of amyloid and tau in AD, as well as immunotherapeutic efforts to date. We also summarize what is known about naturally occurring anti-Aß and tau antibodies in IVIg with a view toward explaining potential mechanisms underlying their therapeutic effects.


Downloads

PDF  (477.57 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Journal of Central Nervous System Disease
This is my first experience working with the journal and it has been the easiest publication process that I can imagine. The links sent make login simple. The revisions are made so quickly. The decisions are made rapidly. We will definitely be working with this journal again.
Dr Chris Bushe (Senior Clinical Research Physician, Lilly, Basingstoke, Hampshire, UK)
More Testimonials

Quick Links


New article and journal news notification services